<?xml version="1.0" encoding="UTF-8"?>
<snippetsTree>
 <snippets file="./PMC5493079/results/search/medproc/results.xml">
  <result pre="P. Juffermans P055 - Cessation of a preexisting chronic antiplatelet" exact="therapy" post="is associated with increased mortality rates in severe sepsis"/>
  <result pre="Singer, H. S. Jafri P099 - Short-term inhaled colistin adjunctive" exact="therapy" post="for ventilator-associated pneumonia Y. Nassar, M. S. Ayad P100"/>
  <result pre="unit (ticu) patients – Tehran, Iran H. Talaie P109 -" exact="Phage therapy" post="against antimicrobial resistance, design of the first clinical study"/>
  <result pre="(ticu) patients – Tehran, Iran H. Talaie P109 - Phage" exact="therapy" post="against antimicrobial resistance, design of the first clinical study"/>
  <result pre="Aldabbagh, R. Khan, Y. Arabi P111 - Does empiric antifungal" exact="therapy" post="improve survival in septic critically ill patients? (immunocompromised excluded)"/>
  <result pre="Multiorgan Donor(PMD) F. Righetti, E. Colombaroli, G. Castellano P147 -" exact="Echocardiography" post="in the potential heart donor exposed to substitution hormonotherapy"/>
  <result pre="M. Cecconi P161 - Analysis of duration of post-operative goal-directed" exact="therapy" post="protocol C. Ostrowska, H. Aya, A. Abbas, J. Mellinghoff,"/>
  <result pre="HES solution do not reduce total fluid requirement in the" exact="therapy" post="of patients with burn shock V. Bagin, V. Rudnov,"/>
  <result pre="0.9 % saline or Plasma-Lyte 148 ® as crystalloid fluid" exact="therapy" post="on gastrointestinal feeding intolerance in mechanically ventilated patients receiving"/>
  <result pre="using 0.9 % saline or Plasma-Lyte® 148 as crystalloid fluid" exact="therapy" post="in adults in ICU after heart surgery S. Reddy,"/>
  <result pre="urinary output: potential parameters for early initiation of renal replacement" exact="therapy" post="K. Maas, H. De Geus P183 - Renal replacement"/>
  <result pre="therapy K. Maas, H. De Geus P183 - Renal replacement" exact="therapy" post="for critically ill patients: an intermittent continuity E. Lafuente,"/>
  <result pre="P184 - A survey of practices related to renal replacement" exact="therapy" post="in critically ill patients in the north of England."/>
  <result pre="28-day mortality in critically ill patients necessitating continuous renal replacement" exact="therapy" post="S. Stads, A. J. Groeneveld P186 - The impact"/>
  <result pre="on outcomes in acute kidney injury patients receiving renal replacement" exact="therapy" post="on the intensive care unit I. Elsayed, N. Ward,"/>
  <result pre="- Citrate regional anticoagulation for post dilution continuous renal replacement" exact="therapy" post="S. Ghabina P189 - Citrate 18 mmol/l improves anticoagulation"/>
  <result pre="P195 - Observations in early vs. late use of cytosorb" exact="therapy" post="in critically ill patients K. Kogelmann, M. Drüner, D."/>
  <result pre="A. Ozcan, C. Kaymak P219 - Anaesthesia procedure and intensive" exact="therapy" post="in patients with neck phlegmon V. A. Artemenko, A."/>
  <result pre="and normal adult breathing profiles during nasal high flow oxygen" exact="therapy" post="L. Sweeney, A . O’ Sullivan, P. Kelly, E."/>
  <result pre="O. Nigeon, M. Lemyze, D. Thevenin, J. Mallat P446 -" exact="Palliative care" post="consultation and intensive care unit admission request: a cohort"/>
  <result pre="who may decide E. Koonthalloor, C. Walsh P449 - Correctly" exact="diagnosing" post="death A. Webber, M. Ashe, K. Smith, P. Jeanrenaud"/>
  <result pre="defined refractory shock as septic shock unresponsive to the conventional" exact="therapy" post="such as adequate fluid resuscitation and vasopressor therapy to"/>
  <result pre="the conventional therapy such as adequate fluid resuscitation and vasopressor" exact="therapy" post="to maintain hemodynamics. Results: The serial change of C1INH"/>
  <result pre="at admission and day 1. The validity of C1INH replacement" exact="therapy" post="in patients with septic shock may lead to a"/>
  <result pre="abdominal sepsis. Recently, blood purification (BF) such as endotoxin absorption" exact="therapy" post="(polymyxin B [PMX] hemoperfusion) and continuous renal replacement therapy"/>
  <result pre="absorption therapy (polymyxin B [PMX] hemoperfusion) and continuous renal replacement" exact="therapy" post="(CRRT) has been carried out for abdominal septic shock."/>
  <result pre="Hospices Civils de Lyon / bioMérieux, Lyon, France Introduction: Despite" exact="therapy" post="improvement septic shock mortality is still around 30 %."/>
  <result pre="criteria poses a diagnostic dilemma that can lead to delayed" exact="therapy" post="or overly aggressive treatment. This study quantified concordance of"/>
  <result pre="to infection, in which the speed and appropriateness of the" exact="therapy" post="administered in the initial hours are likely to influence"/>
  <result pre="increase by disease severity. This probably reflects the difficulty in" exact="diagnosing" post="early sepsis. P039 Vasodilatory plant extracts gel as an"/>
  <result pre="ICU stay, duration of cardiovascular support, need for renal replacement" exact="therapy" post="(RRT) and ICU survival were noted. Results: A total"/>
  <result pre="Biostatistics and analyses, Masaryk University, Brno, Czech Republic Introduction: Vasopressor" exact="therapy" post="is required to sustain life and maintain perfusion in"/>
  <result pre="Italy Introduction: Low-dose vasopressin (VP) recently emerged as a promising" exact="therapy" post="for septic shock[1]. The rationale for its use is"/>
  <result pre="hospital mortality and need for vasopressors, ventilation and renal replacement" exact="therapy" post="(RRT). Results: Of 1,397 ICU admissions 517 had sepsis"/>
  <result pre="liver diseases, chronic kidney failure, hematologic diseases, pregnancy, chronic anticoagulant/antiplatelet" exact="therapy" post="and blood derivates or procoagulant treatments in the last"/>
  <result pre="endogenous anticoagulants. Thereby, ROTEM may be a useful tool in" exact="diagnosing" post="DIC in the critically ill. Table 5 (Abstract P054)."/>
  <result pre="0.468* 0.258 *p &amp;lt; 0.05,**p &amp;lt; 0.01 P055 Cessation of a preexisting chronic antiplatelet" exact="therapy" post="is associated with increased mortality rates in severe sepsis"/>
  <result pre="sepsis [1, 2]. But it remains unclear, if chronic antiplatelet" exact="therapy" post="should be continued or not during severe sepsis and"/>
  <result pre="blood cell (RBC) transfusion in patients with continued chronic antiplatelet" exact="therapy" post="remains to be determined. We hypothesized that the continuation"/>
  <result pre="of a preexisting antiplatelet medication (aspirin, clopidogrel, dipyridamole) during sepsis" exact="therapy" post="reduces mortality rates of severe sepsis and septic shock"/>
  <result pre="represented as percentages and counts. Results: Patients whose preexisting antiplatelet" exact="therapy" post="was continued showed increased mortality rates in contrast to"/>
  <result pre="antiplatelet agents (p &amp;gt; 0.05). Conclusions: The continuation of a chronic antiplatelet" exact="therapy" post="during severe sepsis and septic shock was associated with"/>
  <result pre="for diagnostic results to become available, which can adversely impact" exact="therapy" post="and clinical outcomes. Molecular techniques to diagnose CRBSI are"/>
  <result pre="mechanical ventilation 90% 83.3% Cardiovascular support 90% 100% Renal replacement" exact="therapy" post="20% None Length of stay in ICU in hours"/>
  <result pre="mechanical ventilation. All patients received 3-doses of trivalent anti-botulinum toxin" exact="therapy" post="within 24 hours of clinical diagnosis. The diagnosis was"/>
  <result pre="bacteria which is accompanied by poor outcome due to inappropriate" exact="therapy" post="led to the investigation if adjunctive treatment with Pentaglobin,"/>
  <result pre="87.1 % of the patients during the ICU stay, vasopressor" exact="therapy" post="in 80.6 %, and renal replacement therapy in 51.6"/>
  <result pre="ICU stay, vasopressor therapy in 80.6 %, and renal replacement" exact="therapy" post="in 51.6 %. The overall ICU mortality rate was"/>
  <result pre="invasive mechanical ventilation (95.7 vs. 62.5 %, p = 0.48) and vasopressor" exact="therapy" post="(95.7 vs. 37.5 %, p = 0.002). Conclusions: MERS-CoV infection requiring"/>
  <result pre="4 were treated with proning, 4 needed continuous renal replacement" exact="therapy" post="and one had extracorporeal membrane oxygenation. The hospital mortality"/>
  <result pre="VS 92.0 %). In turn, more patients received appropriate antibiotic" exact="therapy" post="(86.7 % VS 100 %). Of note, 6 patients"/>
  <result pre="Results: N/A Conclusions: The SAATELLITE study represents an innovative pre-emptive" exact="therapy" post="approach to prevent S aureus nosocomial pneumonia in MV"/>
  <result pre="to randomization. Conclusions: The EVADE study represents an innovative pre-emptive" exact="therapy" post="approach to prevent P aeruginosa nosocomial pneumonia in MV"/>
  <result pre="infection management in high-risk patients. P099 Short-term inhaled colistin adjunctive" exact="therapy" post="for ventilator-associated pneumonia Y. Nassar, M. S. Ayad Cairo"/>
  <result pre="colistin (3x 106 IU/day, for 5 days) as an adjunctive" exact="therapy" post="to conventional treatment of VAP (n = 52 pts) or enter"/>
  <result pre="VAP (n = 52 pts) or enter the control group of conventional" exact="therapy" post="only (n = 33 pts). Comparison included microbiological outcome (Day 6"/>
  <result pre="Adjunctive inhaled colistin is safe and effective as an additive" exact="therapy" post="in patients with gram-negative ventilator-associated pneumonia. P100 Effect of"/>
  <result pre="hospital ICU, were without pre-existing kidney injury, and received colistin" exact="therapy" post="72 or more hours were included. Patient demographics, the"/>
  <result pre="Bobi, M. Rigol, A. Torres Hospital Clinic, Barcelona, Spain Introductions:" exact="Nebulization" post="of antibiotics is a promising strategy for the treatment"/>
  <result pre="nebulized F; nebulized AF with Mero administered IV; Mero alone." exact="Nebulization" post="was performed through an in-line vibrating mesh nebulizer (PARI"/>
  <result pre="onset was between 1-15 days (median 4) after initiation of" exact="therapy" post="with resolution within 3 days (median 2) of cessation"/>
  <result pre="to pathogenic organisms. To treat the inflammatory reaction an antibiotic" exact="therapy" post="is fundamental [1]. Effects of disease pattern and intensive"/>
  <result pre="Therefore we analysed changes of beat-to-beat cardiac activity during antibiotic" exact="therapy" post="of intensive care patients with a high resolution electrocardiogram."/>
  <result pre="(p &amp;lt; 0,05). This variation persisted for the first three minutes of" exact="therapy" post="and returns during the next two minutes to their"/>
  <result pre="as nephrotoxicity and bicytopeniasignificantly were decreased in teicoplanin therapy. P109" exact="Phage therapy" post="against antimicrobial resistance, design of the first clinical study"/>
  <result pre="nephrotoxicity and bicytopeniasignificantly were decreased in teicoplanin therapy. P109 Phage" exact="therapy" post="against antimicrobial resistance, design of the first clinical study"/>
  <result pre="control randomized trial ever done in the world about phage" exact="therapy" post="in humans. Results will be available in 2016. Phages"/>
  <result pre="be routinely considered for antibiotic dosing. P111 Does empiric antifungal" exact="therapy" post="improve survival in septic critically ill patients? (immunocompromised excluded)"/>
  <result pre="of invasive candidiasis (IC) remains a major challenge. Delayed antifungal" exact="therapy" post="is known as an independent mortality factor in Septic"/>
  <result pre="in Septic shock attributed to IC [1]. Thus, empiric antifungal" exact="therapy" post="(EAFT) can be indicated in septic patients at risk"/>
  <result pre="acute bleeding. PCC should be used as a first line" exact="therapy" post="for anticoagulation reversal of vitamin k antagonist. References Josepg"/>
  <result pre="transfusion PRBC for 11 % and decreasing volume of infusion" exact="therapy" post="for 19 % compared to patients of 2 ng"/>
  <result pre="is an useful alternative to labINR for guiding blood component" exact="therapy" post="after CPB. Fig. 23 (Abstract P126). ᅟ P127 Disseminated"/>
  <result pre="A major haemorrhage protocol improves the delivery of blood component" exact="therapy" post="and reduces waste in trauma massive transfusion. Injury. 2013,"/>
  <result pre="&amp;amp; Reddy P. Atrial fibrillation after cardiac surgery: does rophylactic" exact="therapy" post="decrease adverse outcomes associated with atrial fibrillation. J Intensive"/>
  <result pre="estimated glomerular filtration rate, and 2) need for renal replacement" exact="therapy" post="during 90 days. The secondary endpoints were 1) length"/>
  <result pre="in serum levels of creatinine and cystatin C, renal replacement" exact="therapy" post="rate (1 of 37 patients in the ANP group"/>
  <result pre="1 - 10). Rhythm control strategy was used as first-line" exact="therapy" post="for the majority of patients: 81 % received intravenous"/>
  <result pre="septic shock. N Engl J Med. 2008 Feb 28;358(9):877-87. P147" exact="Echocardiography" post="in the potential heart donor exposed to substitution hormonotherapy"/>
  <result pre="systolic function, despite the stunning post neurovegetative storm. Reference 1." exact="Echocardiography" post="in the potential heart donor. Venkateswaran RV et al.:"/>
  <result pre="in post-operative patients. P161 Analysis of duration of post-operative goal-directed" exact="therapy" post="protocol C. Ostrowska, H. Aya, A. Abbas, J. Mellinghoff,"/>
  <result pre="describe the timing for achieving targets of the post-operative goal-directed" exact="therapy" post="(GDT) protocol in postoperative patients admitted to ICU in"/>
  <result pre="School, Canberra, Australia Introductions: Fluid bolus administration is a ubiquitous" exact="therapy" post="within Intensive Care, however recent evidence has suggested a"/>
  <result pre="salt solution was the most commonly used for fluid bolus" exact="therapy" post="in our unit, independent of patient disease or severity."/>
  <result pre="injuries, transfusions and management were collected, as well as fluid" exact="therapy" post="and mechanical ventilation during ICU stay. Patients were classified"/>
  <result pre="ventilation duration in non-survivors group. The use of extra renal" exact="therapy" post="was higher in non-survivors group (1 vs 11 p = 0.01)."/>
  <result pre="HES solution do not reduce total fluid requirement in the" exact="therapy" post="of patients with burn shock V. Bagin, V. Rudnov,"/>
  <result pre="to access the efficacy and safety of HES in the" exact="therapy" post="of patients with burn shock. Methods: Design: retrospective cohort"/>
  <result pre="24 patients received 6%HES 130/0,4 in addition to base fluid" exact="therapy" post="with Ringer solution and control group: 25 patients received"/>
  <result pre="for RRT. Addition of HES solution in the early infusion" exact="therapy" post="is not associated with the reduce of total fluid"/>
  <result pre="0.9 % saline or Plasma-Lyte 148 ® as crystalloid fluid" exact="therapy" post="on gastrointestinal feeding intolerance in mechanically ventilated patients receiving"/>
  <result pre="using 0.9 % saline or Plasma-Lyte® 148 as crystalloid fluid" exact="therapy" post="in adults in ICU after heart surgery S. Reddy"/>
  <result pre="trial. All adult heart surgery patients who required crystalloid fluid" exact="therapy" post="in ICU as part of the SPLIT trial [1]"/>
  <result pre="to the potentially fatal INH hepatitis. HAGMA refractory to conventional" exact="therapy" post="is one of the hallmarks of INH toxicity. Though"/>
  <result pre="urinary output: potential parameters for early initiation of renal replacement" exact="therapy" post="K. Maas, H. De Geus Erasmus Medical Centre, Rotterdam,"/>
  <result pre="increased mortality in the critically ill, especially when renal replacement" exact="therapy" post="(RRT) is required. &quot;Early initiation&quot; of RRT and its"/>
  <result pre="patients with any AKI compared with RRT P183 Renal replacement" exact="therapy" post="for critically ill patients: an intermittent continuity E. Lafuente"/>
  <result pre="Castelo, Portugal Introductions: The choice for the right renal replacement" exact="therapy" post="(RRT) for severe acute kidney injury in critically ill"/>
  <result pre="critically ill patients, indications for SLED and continuous renal replacement" exact="therapy" post="(CRRT) in critically ill patients in four Portuguese ICUs."/>
  <result pre="months. All patients with AKI who needed a renal replacement" exact="therapy" post="were enrolled. Data on demographics and clinical characteristics of"/>
  <result pre="CRRT seems to be the ideal mode of renal replacement" exact="therapy" post="for hemodynamically unstable with fluid overloaded. However, in expert"/>
  <result pre="complementary. P184 A survey of practices related to renal replacement" exact="therapy" post="in critically ill patients in the north of England."/>
  <result pre="up- to- date guideline regarding the use of renal replacement" exact="therapy" post="(RRT) within intensive care. We wished to evaluate current"/>
  <result pre="we hope to improve outcomes for those receiving renal replacement" exact="therapy" post="in our units. P185 High initiation creatinine associated with"/>
  <result pre="28-day mortality in critically ill patients necessitating continuous renal replacement" exact="therapy" post="S. Stads 1, A. J. Groeneveld 2 1Ikazia Hospital,"/>
  <result pre="Rotterdam, Netherlands Introductions: Acute kidney injury necessitating continuous renal replacement" exact="therapy" post="(CRRT) in critically ill patients is associated with high"/>
  <result pre="on outcomes in acute kidney injury patients receiving renal replacement" exact="therapy" post="on the intensive care unit I. Elsayed 1, N."/>
  <result pre="renal &amp;amp; patient survival in AKI patients, receiving renal replacement" exact="therapy" post="(RRT) in intensive care (ICU). Methods: We prospectively enrolled"/>
  <result pre="P188 Citrate regional anticoagulation for post dilution continuous renal replacement" exact="therapy" post="S. Ghabina Royal London Hospital, London, UK Introductions: S"/>
  <result pre="(RCA) is an effective anticoagulation technique for continuous renal replacement" exact="therapy" post="(CRRT). Commonly, RCA protocols incorporate citrate within the replacement"/>
  <result pre="of severe sepsis/septic shock. Therefore, CytoSorb was used as adjunctive" exact="therapy" post="in combination with continuous renal replace therapy (CRRT), in"/>
  <result pre="used as adjunctive therapy in combination with continuous renal replace" exact="therapy" post="(CRRT), in order to control the cytokines storm and"/>
  <result pre="a timely use of CytoSorb in combination with the standard" exact="therapy" post="could have benefits in improving patients hemodynamic and helping"/>
  <result pre="83 ± 3.2 P195 Observations in early vs. late use of cytosorb" exact="therapy" post="in critically ill patients K. Kogelmann 1, M. Drüner"/>
  <result pre="to increased cytokine levels [1]. CytoSorb is used as adjunctive" exact="therapy" post="not only in septic multiorgan failure as well as"/>
  <result pre="14 Patients treated additional with cytokine-haemadsorption filter (Cytosorb) as adjunctive" exact="therapy" post="in septic shock or severe SIRS. The focus was"/>
  <result pre="to show the effectiveness of Cytosorb treatment used as adjunctive" exact="therapy" post="in critically ill patients. If there was no decrease"/>
  <result pre="decrease of catecholamine demand and kidney injury persistent after initial" exact="therapy" post="following actual guidelines [2], Cytosorb therapy was initiated. We"/>
  <result pre="injury persistent after initial therapy following actual guidelines [2], Cytosorb" exact="therapy" post="was initiated. We collected data before, during and after"/>
  <result pre="overall survival was 35,7 %. In contrast, survival in Cytosorb" exact="therapy" post="start delay 24 h was 66.7 %. Poor outcome"/>
  <result pre="outcome increased in patients with late start of Cytosorb (survivors:" exact="therapy" post="start delay &amp;lt; 48 h: 50 %, delay &amp;gt; 48 h: none). Cytosorb"/>
  <result pre="therapy start delay &amp;lt; 48 h: 50 %, delay &amp;gt; 48 h: none). Cytosorb" exact="therapy" post="start in nonsurvivors was by far later than in"/>
  <result pre="than in survivors (61,3 h vs 28,8 h). After Cytosorb" exact="therapy" post="we observed pronounced decrease of catecholamine demand (Norepinephrine μg/h"/>
  <result pre="renal failure or late admission to ICU. This implicates a" exact="therapy" post="start not later than 24 – 48 hours. References"/>
  <result pre="given loop diuretics, 10(19 %) started on continuous renal replacement" exact="therapy" post="(CRRT), fluid boluses to 21(39 %). In 1 (2"/>
  <result pre="postrenal obstruction with urineaccumulation. Ultrasound(US) is the procedure of choice" exact="diagnosing" post="this cause of AKI and hence choosing the best"/>
  <result pre="a programme for the education of students and physicians in" exact="diagnosing" post="obstruction via US in an expert like manner. Methods:"/>
  <result pre="the length(cm) of the right kidney of a female volunteer,(ii)" exact="diagnosing" post="postrenal obstruction by evaluating images from US examinations. FARIUS"/>
  <result pre="develop acute renal failure (ARF) and require a renal replacement" exact="therapy" post="(RRT). The best delay to start RRT is a"/>
  <result pre="surgery (ERAS) pathways incorporate the use of goal directed fluid" exact="therapy" post="with cardiac output monitoring perioperatively. Our study aim was"/>
  <result pre="to be around 30 % with need for renal replacement" exact="therapy" post="up to 1 %. [1] We aim to characterize"/>
  <result pre="cadaver-kidney transplantations should be increased. P219 Anaesthesia procedure and intensive" exact="therapy" post="in patients with neck phlegmon V. A. Artemenko, A."/>
  <result pre="to 72 hours after decreasing inflammatory, larynges edema, and trizm." exact="Intubation" post="algorithm: 1. Evaluate risk difficult intubation, trizm and stridor;"/>
  <result pre="UK Introduction: Nasal high flow oxygen (NHFO) is an attractive" exact="therapy" post="for acute hypoxemic respiratory failure (AHRF), with reported comfort,"/>
  <result pre="at present to support use of NHFO rather than conventional" exact="therapy" post="for acute hypoxemic respiratory failure in adults, and further"/>
  <result pre="and normal adult breathing profiles during nasal high flow oxygen" exact="therapy" post="L. Sweeney, A. O’ Sullivan, P. Kelly, E. Mukeria,"/>
  <result pre="to dose consistency by aerosol delivery during nasal high flow" exact="therapy" post="(NHF). We sought to investigate the efficiency of dosing"/>
  <result pre="at both high and low gas flow rates via NHF" exact="therapy" post="is an efficient and highly reproducible means of administration."/>
  <result pre="to evaluate the usefulness of the CL test and corticosteroid" exact="therapy" post="in the prevention of UAO. P226 A device for"/>
  <result pre="daily hydroelectrolitic rebalancing, calculation of individual energy need and symptomatic" exact="therapy" post="was performed. Along with the improvement of general condition,"/>
  <result pre="are not without their limitations. These include blockages and aerosol" exact="therapy" post="(AT) associated issues [3-4]. PH manufacturers have identified the"/>
  <result pre="Non-invasive ventilation (NIV) is commonly used as a first line" exact="therapy" post="for immunocompromised patients with acute respiratory failure, although it"/>
  <result pre="that if it is interact with the noninvasive ventilation (NIV)" exact="therapy" post="in hypercapnic respiratory failure. Because of the frequent diuretic"/>
  <result pre="NIV screened retrospectively. Patients who received asetozolamid during the NIV" exact="therapy" post="excluded from the study. We investigated frequency, risk factors"/>
  <result pre="Rehabilitacion, Mexico City, Mexico Introduction: Mechanical ventilation (MV) is a" exact="therapy" post="for vital support used in a significant proportion of"/>
  <result pre="critically ill patients. The right time to succesfully discontinue this" exact="therapy" post="is a challenge for the intensivist The ecocardiographic evaluation"/>
  <result pre="curves on a global, but not on a regional level." exact="Electrical impedance tomography" post="(EIT) in contrast is an established non-invasive tool to"/>
  <result pre="and 57 % respectively). 57 % of patients underwent physical" exact="therapy" post="within a median of 5 days of starting ECMO"/>
  <result pre="or 1) can do well with mechanical circulatory support. Destination" exact="therapy" post="&amp;amp; commissioning remains a problem within the UK. Reference"/>
  <result pre="92.3 % (AUC 0.85; 95 % CI 0.684-0.945; p &amp;lt; 0.0001) for" exact="diagnosing" post="ARDS in NP. A complex ROC analysis (SPD + P/F ratio"/>
  <result pre="with both acute and acute-on-chronic liver failure. Extracorporeal liver support" exact="therapy" post="(ECLST) could be one of the treatment option. But"/>
  <result pre="high mortality rate without liver transplant, although extracorporeal liver support" exact="therapy" post="improved total bilirubin, creatinine and BUN. Nevertheless, the value"/>
  <result pre="hospital ICU beds in ES-Brazil. 151 critically patients with nutritional" exact="therapy" post="indication were enrolled. This retrospective study (nov13-nov14) we grouped"/>
  <result pre="1.2 g/kgBW/d [1]. Protein is an integral component of nutritional" exact="therapy" post="in critically ill patients which aims to minimise muscle"/>
  <result pre="stay (day+/-SD) 19.85 ± 20.43 26.78 ± 26.90 0.087 Vasopressor" exact="therapy" post="(%) 63.4% 80.0% 0.051 Duration of ventilator (day+/-SD) 14.19"/>
  <result pre="patients may be contraindicated, therefore 5-HTP can become an alternative" exact="therapy" post="in depression of patients in ICU. P294 Parenteral selenium"/>
  <result pre="on infections (P = 0.15). There was no effect of IV selenium" exact="therapy" post="on ICU LOS, hospital LOS, and ventilator days. Result"/>
  <result pre="1.04; P = 0.18) RR 0.95 (95% CI 0.85, 1.06; P = 0.36) Combined" exact="therapy" post="RR 1.08 (95% CI 0.93, 1.25; P = 0.33) RR 0.90"/>
  <result pre="intravenous drip infusion of a diuretic solution and renal replacement" exact="therapy" post="requirement in ICU. The study was conducted by an"/>
  <result pre="for CPR in a bundle approach including epinephrine and post-ROSC" exact="therapy" post="protocol. References Zamiri N, Massé S, Ramadeen A, Kusha"/>
  <result pre="and neurological outcome in patients with our without renal replacement" exact="therapy" post="(RRT). Methods Prospective cohort study at Oslo University Hospital,"/>
  <result pre="patients were randomly allocated in 2 groups to receive standard" exact="therapy" post="or 1800 mg of L-carnitine/ day together with standard"/>
  <result pre="therapy or 1800 mg of L-carnitine/ day together with standard" exact="therapy" post="for 3 days. Plasma levels of valproic acid and"/>
  <result pre="in patients equivocal LP findings or recurrent symptoms was CT" exact="Angiography" post="[2]. Conclusions The majority of patients presenting with acute"/>
  <result pre="delayed presentation or risk factors for SAH benefit from CT" exact="Angiography" post="unless contra-indicated. Our findings will be presented as an"/>
  <result pre="1.5 g twice daily (23.1 %). Median duration of LEV" exact="therapy" post="was 7 days. Seizures occurred in 7 patients during"/>
  <result pre="S, Nindra P, Ray S: Inhaled NO as a salvage" exact="therapy" post="in ARDS 2. Ferrando C, Moreno J, Soro M,"/>
  <result pre="30 %, respectively (0,03). Conclusions Dexmedetomidine addition to basic AWS" exact="therapy" post="with benzodiazepines and antipsychotics, may decrease risk of PTSD"/>
  <result pre="cardiovascular dysfunction, in 57.40 % of patients (N = 31). Renal replacement" exact="therapy" post="was required in 11 cases. Invasive ventilation was performed"/>
  <result pre="and INR, septic shock, noninvasive ventilation before intubation, renal replacement" exact="therapy" post="and chemotherapy administration in the ICU. Results: In the"/>
  <result pre="19 (15.4 %) patients during ICU stay. New renal replacement" exact="therapy" post="for acute kidney injury was used in 18 (14.6"/>
  <result pre="5.67; 95 % confidence interval, 1.92-16.75) and new renal replacement" exact="therapy" post="(odds ratio, 13.59; 95 % confidence interval, 1.14-161.93) were"/>
  <result pre="mortality (69 %). Male gender, septic shock and renal replacement" exact="therapy" post="were independent predictors of mortality. P403 Patient-important outcomes in"/>
  <result pre="invasive or non-invasive mechanical ventilation, vasopressor or commencing renal replacement" exact="therapy" post="and antibiotic treatment. Reference Orsini J, Blaak C, Shamian"/>
  <result pre="that mobilization of patients on low dose of vasoactive drugs" exact="therapy" post="may be possible and safe, with little complications and"/>
  <result pre="and appears safe in this short observation period. Interactive game" exact="therapy" post="may complement existing rehabilitation techniques and increase motivation for"/>
  <result pre="referred to palliative care, with its attendant cost savings. Conclusions:" exact="Palliative care" post="in the ICU is an important part of management"/>
  <result pre="of Critical Care Medicine. Crit Care Med. 1998 Mar;26(3):607-10. P446" exact="Palliative care" post="consultation and intensive care unit admission request: a cohort"/>
  <result pre="cardiac arrest or `Brain Dead.all patients who had limitation of" exact="therapy" post="had family consensus,of which 2 were autonomous decision of"/>
  <result pre="reasons for withdrawal of care was either unresponsive to maximal" exact="therapy" post="or irreversible neurologic status,The optimal use of resources and"/>
  <result pre="associated with increased satisfaction. Crit Care Med 2004;32:1484-1488 P449 Correctly" exact="diagnosing" post="death A. Webber, M. Ashe, K. Smith, P. Jeanrenaud"/>
  <result pre="out the reviews were not involved in the process of" exact="diagnosing" post="death in order not to bias the study findings."/>
 </snippets>
</snippetsTree>
